SMTL ID : 5od7.1

Hsp90 inhibitor desolvation as a rationale to steer on-rates and impact residence time

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x H0T: [2-azanyl-6-[2-(4-methylpiperazin-1-yl)sulfonylphenyl]quinazolin-4-yl]-(1,3-dihydroisoindol-2-yl)methanone(Non-covalent)

H0T.1: 14 residues within 4Å: Chain A: N.44, S.45, D.47, A.48, D.86, I.89, G.90, M.91, D.95, L.100, F.131, Y.132, W.155, T.177 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:A.48, A:I.89, A:L.100, A:L.100 Hydrogen bonds: A:N.44, A:T.177, A:T.177 Water bridges: A:S.45, A:S.45, A:S.45, A:D.86, A:D.86, A:T.177 Salt bridges: A:D.47, A:D.86 pi-Stacking: A:F.131, A:W.155

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schuetz, D.A. et al., Ligand Desolvation Steers On-Rate and Impacts Drug Residence Time of Heat Shock Protein 90 (Hsp90) Inhibitors. J.Med.Chem. (2018)

Release Date

2018-11-21

Peptides

Heat shock protein HSP 90-alpha: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Heat shock protein HSP 90-alpha

Related Entries With Identical Sequence